These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34911481)

  • 1. Changes in the use of diabetes drugs among community-dwelling people with Alzheimer's disease.
    López-Rubio C; Koponen M; Lampela P; Taipale H; Tanskanen A; Bell JS; Tolppanen AM; Hartikainen S
    BMC Geriatr; 2021 Dec; 21(1):701. PubMed ID: 34911481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of cardiovascular drug use before and after diagnosis of Alzheimer's disease.
    Vu M; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Kettunen R; Hartikainen S; Tolppanen AM
    Int J Cardiol; 2020 Feb; 300():221-225. PubMed ID: 31810814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.
    Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1729-37. PubMed ID: 25453487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease.
    Sarycheva T; Taipale H; Lavikainen P; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen AM
    J Alzheimers Dis; 2018; 66(1):387-395. PubMed ID: 30282366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and Risk of Alzheimer's Disease Among Community-Dwelling People With Diabetes: A National Case-Control Study.
    Sluggett JK; Koponen M; Bell JS; Taipale H; Tanskanen A; Tiihonen J; Uusitupa M; Tolppanen AM; Hartikainen S
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31778170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incident hip fractures among community dwelling persons with Alzheimer's disease in a Finnish nationwide register-based cohort.
    Tolppanen AM; Lavikainen P; Soininen H; Hartikainen S
    PLoS One; 2013; 8(3):e59124. PubMed ID: 23527106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug use in persons with and without Alzheimer's disease aged 90 years or more.
    Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of comorbidities on survival in persons with Alzheimer's disease: a matched cohort study.
    Rajamaki B; Hartikainen S; Tolppanen AM
    BMC Geriatr; 2021 Mar; 21(1):173. PubMed ID: 33750334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.
    Taipale H; Lampela P; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
    J Alzheimers Dis; 2019; 68(1):127-136. PubMed ID: 30775987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study.
    Tolppanen AM; Taipale H; Koponen M; Lavikainen P; Tanskanen A; Tiihonen J; Hartikainen S
    BMJ Open; 2016 Jul; 6(7):e012100. PubMed ID: 27412109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term use of opioids for nonmalignant pain among community-dwelling persons with and without Alzheimer disease in Finland: a nationwide register-based study.
    Hamina A; Taipale H; Tanskanen A; Tolppanen AM; Karttunen N; Pylkkänen L; Tiihonen J; Hartikainen S
    Pain; 2017 Feb; 158(2):252-260. PubMed ID: 28092324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease.
    Orsel K; Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S
    Eur Neuropsychopharmacol; 2018 Nov; 28(11):1260-1269. PubMed ID: 30153953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital care and drug costs from five years before until two years after the diagnosis of Alzheimer's disease in a Finnish nationwide cohort.
    Taipale H; Purhonen M; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S
    Scand J Public Health; 2016 Mar; 44(2):150-8. PubMed ID: 26553247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of cataract surgeries in people with and without Alzheimer's disease.
    Hokkinen K; Kaarniranta K; Jämsen E; Lampela P; Hartikainen S; Tolppanen AM
    Acta Ophthalmol; 2022 Feb; 100(1):68-73. PubMed ID: 33988311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of pneumonia in persons with and without Alzheimer's disease: a matched cohort study.
    Järvinen H; Tolppanen AM; Hartikainen S
    BMC Geriatr; 2023 Apr; 23(1):227. PubMed ID: 37038120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer's disease-A nationwide register-based study in Finland.
    Karttunen N; Taipale H; Hamina A; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
    Int J Geriatr Psychiatry; 2019 Feb; 34(2):280-288. PubMed ID: 30370943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease.
    Hamina A; Lavikainen P; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S; Taipale H
    Int Psychogeriatr; 2018 Jul; 30(7):947-956. PubMed ID: 29559009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease.
    Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    Int Clin Psychopharmacol; 2015 Jul; 30(4):202-8. PubMed ID: 26011780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin discontinuation in persons with and without Alzheimer's disease.
    Vu M; Kettunen R; Tolppanen AM; Hartikainen S; Taipale H
    Eur J Clin Pharmacol; 2022 Jul; 78(7):1145-1153. PubMed ID: 35449421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.
    Lampela P; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
    J Alzheimers Dis; 2017; 56(1):119-128. PubMed ID: 27911327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.